
Cleveland Cavaliers · — · #—
—
| Period | GP | MIN | PTS | REB | AST | PRA | STL | BLK | TOV | 2PM | 2PA | 2P% | 3PM | 3PA | 3P% | FTM | FTA | FT% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Last 3 | 3 | 34.0 | 31.3 | 6.3 | 4.3 | 42.0 | 1.0 | 0.7 | 3.3 | 9.3 | 14.0 |
| 66.7% |
| 2.3 |
| 6.0 |
| 38.9% |
| 5.7 |
| 6.0 |
| 94.4% |
| Last 5 | 5 | 32.4 | 27.6 | 4.8 | 4.8 | 37.2 | 0.8 | 0.4 | 2.8 | 7.8 | 11.8 | 66.1% | 2.0 | 5.8 | 34.5% | 6.0 | 6.4 | 93.8% |
| Last 10 | 10 | 33.3 | 26.0 | 5.1 | 4.3 | 35.4 | 1.0 | 0.3 | 2.2 | 6.8 | 11.9 | 57.1% | 2.1 | 6.0 | 35.0% | 6.1 | 6.7 | 91.0% |
| Last 20 | 20 | 32.6 | 25.2 | 4.5 | 5.0 | 34.8 | 1.4 | 0.2 | 2.2 | 6.6 | 11.6 | 57.1% | 2.0 | 6.5 | 31.3% | 5.8 | 6.5 | 90.0% |
| Season | 70 | 33.5 | 27.9 | 4.5 | 5.7 | 38.1 | 1.5 | 0.3 | 2.8 | 6.5 | 11.2 | 57.7% | 3.2 | 8.8 | 36.4% | 5.3 | 6.1 | 86.5% |
high on-ball creation, high assist rate, low contested shots per minute, low offensive rebounding
2025-26 season · fitted over 2022-23–2025-26
Style profile over 446 qualified players (8+ games, 10+ min/game). 100% is an identical profile; 50% is unrelated.
| Date | Matchup | W/L | MIN | PTS | REB | AST | STL | BLK | TOV | FGM | FGA | FG% | 3PM | 3PA | 3P% | FTM | FTA | FT% | +/- |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-04-08 | CLE vs. ATL | W | 34.7 | 31 | 7 | 4 | 0 | 1 | 2 | 12 | 19 | 63.2% | 1 | 4 | 25.0% | 6 | 6 | 100.0% | 20.0 |
| 2026-04-05 | CLE vs. IND | W | 32.9 | 38 | 6 | 6 | 1 | 0 | 3 | 16 | 27 | 59.3% | 2 | 7 | 28.6% | 4 | 5 | 80.0% | 8.0 |
| 2026-04-02 | CLE @ GSW | W | 34.4 | 25 | 6 | 3 | 2 | 1 | 5 | 7 | 14 | 50.0% | 4 | 7 | 57.1% | 7 | 7 | 100.0% | 1.0 |
| 2026-03-31 | CLE @ LAL | L | 24.2 | 10 | 3 | 6 | 0 | 0 | 2 | 4 | 10 | 40.0% | 0 | 3 | 0.0% | 2 | 2 | 100.0% | -24.0 |
| 2026-03-30 | CLE @ UTA | W | 35.8 | 34 | 2 | 5 | 1 | 0 | 2 | 10 | 18 | 55.6% | 3 | 8 | 37.5% | 11 | 12 | 91.7% | 11.0 |
| 2026-03-27 | CLE vs. MIA | W | 30.6 | 6 | 4 | 6 | 4 | 0 | 2 | 1 | 10 | 10.0% | 0 | 3 | 0.0% | 4 | 4 | 100.0% | 14.0 |
| 2026-03-25 | CLE vs. MIA | L | 33.2 | 28 | 6 | 4 | 0 | 0 | 3 | 12 | 22 | 54.5% | 4 | 9 | 44.4% | 0 | 0 | 0.0% | -21.0 |
| 2026-03-24 | CLE vs. ORL | W | 34.7 | 42 | 2 | 3 | 0 | 0 | 2 | 14 | 22 | 63.6% | 3 | 7 | 42.9% | 11 | 11 | 100.0% | 2.0 |
| 2026-03-21 | CLE @ NOP | W | 39.0 | 27 | 7 | 3 | 1 | 0 | 1 | 9 | 23 | 39.1% | 3 | 8 | 37.5% | 6 | 7 | 85.7% | -3.0 |
| 2026-03-17 | CLE @ MIL | W | 33.9 | 19 | 8 | 3 | 1 | 1 | 0 | 4 | 14 | 28.6% | 1 | 4 | 25.0% | 10 | 13 | 76.9% | -15.0 |
| 2026-03-15 | CLE vs. DAL | L | 39.1 | 26 | 1 | 11 | 2 | 0 | 1 | 10 | 24 | 41.7% | 4 | 11 | 36.4% | 2 | 2 | 100.0% | -4.0 |
| 2026-03-13 | CLE @ DAL | W | 28.8 | 24 | 2 | 8 | 2 | 0 | 2 | 11 | 16 | 68.8% | 1 | 4 | 25.0% | 1 | 1 | 100.0% | 6.0 |
| 2026-03-11 | CLE @ ORL | L | 36.1 | 25 | 5 | 5 | 1 | 0 | 3 | 9 | 24 | 37.5% | 4 | 13 | 30.8% | 3 | 3 | 100.0% | 0.0 |
| 2026-03-09 | CLE vs. PHI | W | 31.2 | 17 | 3 | 6 | 2 | 0 | 0 | 4 | 11 | 36.4% | 0 | 2 | 0.0% | 9 | 9 | 100.0% | 10.0 |
| 2026-03-08 | CLE vs. BOS | L | 33.5 | 30 | 7 | 5 | 1 | 2 | 0 | 9 | 18 | 50.0% | 3 | 9 | 33.3% | 9 | 11 | 81.8% | 8.0 |
| 2026-02-24 | CLE vs. NYK | W | 31.4 | 23 | 5 | 4 | 3 | 0 | 3 | 5 | 18 | 27.8% | 2 | 8 | 25.0% | 11 | 14 | 78.6% | 21.0 |
| 2026-02-22 | CLE @ OKC | L | 35.1 | 20 | 7 | 5 | 2 | 0 | 3 | 9 | 19 | 47.4% | 0 | 6 | 0.0% | 2 | 3 | 66.7% | -1.0 |
| 2026-02-20 | CLE @ CHA | W | 34.3 | 32 | 3 | 4 | 2 | 0 | 3 | 9 | 22 | 40.9% | 2 | 7 | 28.6% | 12 | 13 | 92.3% | -4.0 |
| 2026-02-19 | CLE vs. BKN | W | 20.7 | 17 | 3 | 5 | 0 | 0 | 2 | 7 | 12 | 58.3% | 2 | 4 | 50.0% | 1 | 1 | 100.0% | 37.0 |
| 2026-02-11 | CLE vs. WAS | W | 27.9 | 30 | 3 | 5 | 2 | 0 | 5 | 11 | 19 | 57.9% | 2 | 7 | 28.6% | 6 | 6 | 100.0% | 11.0 |
| 2026-02-09 | CLE @ DEN | W | 34.1 | 32 | 1 | 10 | 2 | 2 | 2 | 11 | 23 | 47.8% | 3 | 10 | 30.0% | 7 | 8 | 87.5% | 3.0 |
| 2026-02-07 | CLE @ SAC | W | 34.6 | 35 | 2 | 4 | 2 | 2 | 3 | 13 | 24 | 54.2% | 2 | 8 | 25.0% | 7 | 7 | 100.0% | 12.0 |
| 2026-02-04 | CLE @ LAC | W | 30.1 | 29 | 5 | 9 | 4 | 0 | 2 | 10 | 19 | 52.6% | 3 | 9 | 33.3% | 6 | 6 | 100.0% | 24.0 |
| 2026-02-01 | CLE @ POR | W | 31.5 | 14 | 0 | 9 | 2 | 1 | 3 | 6 | 15 | 40.0% | 2 | 7 | 28.6% | 0 | 0 | 0.0% | 6.0 |
| 2026-01-30 | CLE @ PHX | L | 27.7 | 16 | 3 | 6 | 1 | 0 | 8 | 6 | 12 | 50.0% | 3 | 8 | 37.5% | 1 | 1 | 100.0% | -10.0 |
| 2026-01-28 | CLE vs. LAL | W | 28.7 | 25 | 5 | 5 | 1 | 0 | 0 | 9 | 21 | 42.9% | 3 | 9 | 33.3% | 4 | 4 | 100.0% | 11.0 |
| 2026-01-26 | CLE vs. ORL | W | 35.1 | 45 | 4 | 4 | 1 | 0 | 4 | 15 | 25 | 60.0% | 5 | 8 | 62.5% | 10 | 12 | 83.3% | 23.0 |
| 2026-01-24 | CLE @ ORL | W | 37.6 | 36 | 5 | 9 | 2 | 0 | 3 | 15 | 30 | 50.0% | 2 | 8 | 25.0% | 4 | 5 | 80.0% | 15.0 |
| 2026-01-23 | CLE vs. SAC | W | 34.2 | 33 | 5 | 8 | 1 | 0 | 1 | 11 | 25 | 44.0% | 5 | 12 | 41.7% | 6 | 7 | 85.7% | 5.0 |
| 2026-01-21 | CLE @ CHA | W | 37.5 | 24 | 3 | 6 | 1 | 0 | 8 | 8 | 20 | 40.0% | 2 | 8 | 25.0% | 6 | 7 | 85.7% | -3.0 |
| 2026-01-19 | CLE vs. OKC | L | 35.0 | 19 | 4 | 3 | 3 | 0 | 1 | 5 | 18 | 27.8% | 1 | 9 | 11.1% | 8 | 11 | 72.7% | -26.0 |
| 2026-01-16 | CLE @ PHI | W | 38.9 | 13 | 9 | 12 | 1 | 0 | 6 | 4 | 13 | 30.8% | 4 | 7 | 57.1% | 1 | 2 | 50.0% | -2.0 |
| 2026-01-14 | CLE @ PHI | W | 33.3 | 35 | 7 | 9 | 1 | 0 | 1 | 11 | 22 | 50.0% | 5 | 12 | 41.7% | 8 | 8 | 100.0% | 29.0 |
| 2026-01-12 | CLE vs. UTA | L | 34.0 | 21 | 3 | 2 | 1 | 0 | 0 | 7 | 18 | 38.9% | 4 | 9 | 44.4% | 3 | 3 | 100.0% | -12.0 |
| 2026-01-10 | CLE vs. MIN | W | 31.4 | 28 | 3 | 8 | 1 | 0 | 1 | 9 | 21 | 42.9% | 4 | 10 | 40.0% | 6 | 7 | 85.7% | 1.0 |
| 2026-01-08 | CLE @ MIN | L | 36.8 | 30 | 7 | 8 | 1 | 0 | 4 | 10 | 20 | 50.0% | 2 | 8 | 25.0% | 8 | 9 | 88.9% | 4.0 |
| 2026-01-04 | CLE vs. DET | L | 33.1 | 30 | 6 | 3 | 3 | 0 | 2 | 10 | 21 | 47.6% | 3 | 10 | 30.0% | 7 | 9 | 77.8% | 10.0 |
| 2026-01-02 | CLE vs. DEN | W | 35.1 | 33 | 6 | 5 | 1 | 0 | 4 | 14 | 24 | 58.3% | 5 | 12 | 41.7% | 0 | 2 | 0.0% | 10.0 |
| 2025-12-31 | CLE vs. PHX | W | 29.9 | 34 | 10 | 7 | 2 | 1 | 4 | 10 | 18 | 55.6% | 4 | 7 | 57.1% | 10 | 12 | 83.3% | 17.0 |
| 2025-12-29 | CLE @ SAS | W | 35.3 | 10 | 2 | 7 | 3 | 0 | 3 | 3 | 12 | 25.0% | 2 | 9 | 22.2% | 2 | 2 | 100.0% | 15.0 |
| 2025-12-27 | CLE @ HOU | L | 30.4 | 16 | 3 | 6 | 2 | 1 | 1 | 7 | 17 | 41.2% | 2 | 5 | 40.0% | 0 | 1 | 0.0% | -3.0 |
| 2025-12-25 | CLE @ NYK | L | 32.9 | 34 | 7 | 6 | 4 | 0 | 1 | 12 | 25 | 48.0% | 4 | 9 | 44.4% | 6 | 6 | 100.0% | 2.0 |
| 2025-12-23 | CLE vs. NOP | W | 29.7 | 27 | 4 | 4 | 1 | 0 | 3 | 11 | 16 | 68.8% | 2 | 6 | 33.3% | 3 | 4 | 75.0% | 19.0 |
| 2025-12-22 | CLE vs. CHA | W | 28.7 | 30 | 4 | 5 | 0 | 0 | 3 | 10 | 18 | 55.6% | 6 | 11 | 54.5% | 4 | 4 | 100.0% | 10.0 |
| 2025-12-17 | CLE @ CHI | L | 32.5 | 32 | 1 | 5 | 0 | 0 | 3 | 11 | 23 | 47.8% | 4 | 9 | 44.4% | 6 | 6 | 100.0% | -15.0 |
| 2025-12-14 | CLE vs. CHA | L | 37.9 | 17 | 2 | 7 | 2 | 1 | 2 | 6 | 24 | 25.0% | 1 | 11 | 9.1% | 4 | 5 | 80.0% | -12.0 |
| 2025-12-12 | CLE @ WAS | W | 35.2 | 48 | 4 | 4 | 2 | 0 | 3 | 17 | 31 | 54.8% | 8 | 15 | 53.3% | 6 | 6 | 100.0% | 9.0 |
| 2025-12-06 | CLE vs. GSW | L | 37.2 | 29 | 4 | 3 | 0 | 1 | 2 | 11 | 26 | 42.3% | 7 | 14 | 50.0% | 0 | 0 | 0.0% | 8.0 |
| 2025-12-05 | CLE vs. SAS | W | 31.8 | 28 | 2 | 8 | 3 | 0 | 5 | 9 | 17 | 52.9% | 1 | 5 | 20.0% | 9 | 11 | 81.8% | 18.0 |
| 2025-12-03 | CLE vs. POR | L | 34.4 | 33 | 5 | 5 | 1 | 0 | 4 | 12 | 26 | 46.2% | 3 | 13 | 23.1% | 6 | 6 | 100.0% | -15.0 |
| 2025-12-01 | CLE @ IND | W | 34.5 | 43 | 9 | 6 | 0 | 0 | 3 | 16 | 27 | 59.3% | 4 | 10 | 40.0% | 7 | 9 | 77.8% | 22.0 |
| 2025-11-30 | CLE vs. BOS | L | 38.7 | 18 | 7 | 8 | 3 | 0 | 5 | 7 | 16 | 43.8% | 3 | 7 | 42.9% | 1 | 2 | 50.0% | 8.0 |
| 2025-11-28 | CLE @ ATL | L | 35.4 | 42 | 3 | 3 | 1 | 0 | 4 | 15 | 28 | 53.6% | 7 | 15 | 46.7% | 5 | 5 | 100.0% | 0.0 |
| 2025-11-24 | CLE @ TOR | L | 33.8 | 17 | 1 | 8 | 1 | 0 | 2 | 6 | 20 | 30.0% | 3 | 12 | 25.0% | 2 | 2 | 100.0% | -22.0 |
| 2025-11-23 | CLE vs. LAC | W | 32.6 | 37 | 8 | 6 | 1 | 0 | 2 | 14 | 22 | 63.6% | 5 | 9 | 55.6% | 4 | 4 | 100.0% | 26.0 |
| 2025-11-21 | CLE vs. IND | W | 34.2 | 32 | 9 | 5 | 1 | 0 | 5 | 11 | 22 | 50.0% | 4 | 11 | 36.4% | 6 | 8 | 75.0% | 13.0 |
| 2025-11-19 | CLE vs. HOU | L | 34.1 | 21 | 3 | 2 | 2 | 0 | 4 | 8 | 17 | 47.1% | 3 | 9 | 33.3% | 2 | 2 | 100.0% | -18.0 |
| 2025-11-17 | CLE vs. MIL | W | 35.8 | 37 | 5 | 7 | 1 | 0 | 2 | 14 | 22 | 63.6% | 4 | 8 | 50.0% | 5 | 7 | 71.4% | 7.0 |
| 2025-11-15 | CLE vs. MEM | W | 32.9 | 30 | 5 | 5 | 2 | 0 | 4 | 10 | 21 | 47.6% | 4 | 13 | 30.8% | 6 | 9 | 66.7% | 4.0 |
| 2025-11-13 | CLE vs. TOR | L | 35.7 | 31 | 6 | 6 | 1 | 2 | 7 | 7 | 18 | 38.9% | 2 | 9 | 22.2% | 15 | 17 | 88.2% | -18.0 |
| 2025-11-10 | CLE @ MIA | L | 40.9 | 28 | 15 | 8 | 1 | 0 | 1 | 10 | 28 | 35.7% | 3 | 16 | 18.8% | 5 | 6 | 83.3% | 14.0 |
| 2025-11-08 | CLE vs. CHI | W | 35.4 | 29 | 6 | 6 | 1 | 0 | 2 | 10 | 24 | 41.7% | 5 | 12 | 41.7% | 4 | 4 | 100.0% | 14.0 |
| 2025-11-07 | CLE @ WAS | W | 25.6 | 24 | 5 | 5 | 4 | 1 | 2 | 8 | 20 | 40.0% | 4 | 10 | 40.0% | 4 | 4 | 100.0% | 22.0 |
| 2025-11-05 | CLE vs. PHI | W | 35.1 | 46 | 4 | 8 | 1 | 0 | 2 | 15 | 21 | 71.4% | 6 | 11 | 54.5% | 10 | 10 | 100.0% | 17.0 |
| 2025-11-02 | CLE vs. ATL | W | 35.9 | 37 | 2 | 5 | 2 | 1 | 3 | 12 | 21 | 57.1% | 8 | 15 | 53.3% | 5 | 5 | 100.0% | 9.0 |
| 2025-10-29 | CLE @ BOS | L | 31.9 | 15 | 4 | 6 | 0 | 1 | 3 | 5 | 12 | 41.7% | 5 | 9 | 55.6% | 0 | 2 | 0.0% | -6.0 |
| 2025-10-27 | CLE @ DET | W | 29.5 | 35 | 1 | 2 | 0 | 0 | 5 | 13 | 18 | 72.2% | 2 | 4 | 50.0% | 7 | 8 | 87.5% | 38.0 |
| 2025-10-26 | CLE vs. MIL | W | 33.4 | 24 | 3 | 4 | 1 | 0 | 5 | 9 | 20 | 45.0% | 1 | 8 | 12.5% | 5 | 8 | 62.5% | 2.0 |
| 2025-10-24 | CLE @ BKN | W | 34.9 | 35 | 2 | 5 | 3 | 0 | 3 | 10 | 15 | 66.7% | 6 | 10 | 60.0% | 9 | 12 | 75.0% | 22.0 |
| 2025-10-22 | CLE @ NYK | L | 35.9 | 31 | 2 | 5 | 2 | 1 | 3 | 12 | 25 | 48.0% | 2 | 9 | 22.2% | 5 | 5 | 100.0% | -14.0 |